Regulatory mechanism of transforming growth factor-beta 1 on mechanical properties of tissue engineered heart valve
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

Supported by National Natural Science Foundation of China (30571839,30600608).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To observe whether transforming growth factor-beta 1 (TGF-β1) can improve the mechanical properties of tissue engineered heart valve (TEHV) prepared by TGF-β1 and myofibroblasts.Methods: Myofibroblasts were isolated,cultured,identified,and seeded onto the decellularized aortic valve leaflet.In the experimental group,TEHV were cultured with DMEM containing 10 ng/ml TGF-β1 for 14 days.In the control group,TEHV were cultured with DMEM only for 14 days.The contents of lysyl oxidase (LOX) and hydroxyproline,the expression of LOX and COLL-1 mRNA,and the mechanical properties of the TEHVs were analyzed in each group.Results: The contents of LOX and hydroxyproline,expression of LOX and COLL-1 mRNA,Max-load,and Max-stress were significantly higher in the experimental group than those in the control group (all P<0.05).However,the experimental and control group showed comparable values of Max-strain and elastic modulus.Conclusion: TGF-β1 can increase expression of LOX and COLL-1 mRNA in the seeded cells during TEHV construction,increasing the production and cross-linking of collagen,and improve the mechanical properties of the TEHV.

    Reference
    Related
    Cited by
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 22,2008
  • Revised:December 05,2008
  • Adopted:December 11,2008
  • Online: February 17,2009
  • Published:
Article QR Code